Literature DB >> 16772543

The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

A James Hanje1, Brett Fortune, Ming Song, Daniell Hill, Craig McClain.   

Abstract

Almost all patients with liver disease, especially advanced liver disease, have some evidence of malnutrition, including mineral/vitamin deficiency. A major health trend in the United States has been the significant growth in the use of complementary and alternative medicine (CAM), including nutrition supplements and herbal agents. In the 1990s, the United States government created the National Center for Complementary and Alternative Medicine (NCCAM), as well as the Office on Dietary Supplements, to extend our knowledge in these areas. CAM users are often highly educated and frequently use CAM therapy for chronic diseases, including chronic liver disease. Indeed, most studies suggest that patients with chronic liver disease frequently use nutrition supplements and CAM agents in addition to their traditional medicines. The purpose of this review is to provide an update on the role of nutrition supplements and herbals in liver disease. This article will focus mainly on 7 selected agents (vitamin E, zinc, magnesium, S-adenosylmethionine, betaine, silymarin, and glycyrrhizin), for which there have been not only in vitro and animal studies but also human clinical trials, and we will review both potential efficacy and safety issues.

Entities:  

Mesh:

Year:  2006        PMID: 16772543      PMCID: PMC4239999          DOI: 10.1177/0115426506021003255

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  204 in total

1.  The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

Authors:  Y Arase; K Ikeda; N Murashima; K Chayama; A Tsubota; I Koida; Y Suzuki; S Saitoh; M Kobayashi; H Kumada
Journal:  Cancer       Date:  1997-04-15       Impact factor: 6.860

2.  Acute hepatitis induced by greater celandine (Chelidonium majus).

Authors:  J Benninger; H T Schneider; D Schuppan; T Kirchner; E G Hahn
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

3.  Effects of glycyrrhizin on immune-mediated cytotoxicity.

Authors:  M Yoshikawa; Y Matsui; H Kawamoto; N Umemoto; K Oku; M Koizumi; J Yamao; S Kuriyama; H Nakano; N Hozumi; S Ishizaka; H Fukui
Journal:  J Gastroenterol Hepatol       Date:  1997-03       Impact factor: 4.029

4.  NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis.

Authors:  Aileen Dela Peña; Isabelle Leclercq; Jacqueline Field; Jacob George; Brett Jones; Geoffrey Farrell
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

Review 5.  Black cohosh and other herbal remedies associated with acute hepatitis.

Authors:  Peter W Whiting; Andrew Clouston; Paul Kerlin
Journal:  Med J Aust       Date:  2002-10-21       Impact factor: 7.738

6.  Effects of singly administered betaine on hepatotoxicity of chloroform in mice.

Authors:  S K Kim; Y C Kim; Y C Kim
Journal:  Food Chem Toxicol       Date:  1998-08       Impact factor: 6.023

7.  Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis.

Authors:  D B Hill; S Barve; S Joshi-Barve; C McClain
Journal:  J Lab Clin Med       Date:  2000-05

8.  Vitamin E treatment in pediatric obesity-related liver disease: a randomized study.

Authors:  Pietro Vajro; Claudia Mandato; Adriana Franzese; Edmondo Ciccimarra; Stefania Lucariello; Marcella Savoia; Grazia Capuano; Fiorella Migliaro
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-01       Impact factor: 2.839

9.  [Hepatitis observed during a treatment with a drug or tea containing Wild Germander. Evaluation of 26 cases reported to the Regional Centers of Pharmacovigilance].

Authors:  A Castot; D Larrey
Journal:  Gastroenterol Clin Biol       Date:  1992

10.  Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis.

Authors:  O Riggio; M Merli; L Capocaccia; M Caschera; A Zullo; G Pinto; E Gaudio; A Franchitto; R Spagnoli; E D'Aquilino
Journal:  Hepatology       Date:  1992-09       Impact factor: 17.425

View more
  11 in total

Review 1.  Alcoholic liver disease and malnutrition.

Authors:  Craig J McClain; Shirish S Barve; Ashutosh Barve; Luis Marsano
Journal:  Alcohol Clin Exp Res       Date:  2011-02-01       Impact factor: 3.455

2.  Nutrition in Patients With Cirrhosis.

Authors:  Craig J McClain
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-08

Review 3.  Neurological complications post-liver transplantation: impact of nutritional status.

Authors:  Chantal Bemeur
Journal:  Metab Brain Dis       Date:  2012-11-06       Impact factor: 3.584

Review 4.  Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Authors:  Moon-Sun Kim; Madeleine Ong; Xianqin Qu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

5.  Taurine Attenuates Hepatic Inflammation in Chronic Alcohol-Fed Rats Through Inhibition of TLR4/MyD88 Signaling.

Authors:  Chao-Jen Lin; Chun-Ching Chiu; Yi-Chen Chen; Mu-Lin Chen; Tsai-Ching Hsu; Bor-Show Tzang
Journal:  J Med Food       Date:  2015-06-19       Impact factor: 2.786

Review 6.  COVID-19 and liver dysfunction: What nutritionists need to know.

Authors:  Ming-Ke Wang; Xue-Lu Yu; Li-Yun Zhou; Hong-Mei Si; Ju-Fen Hui; Deng-Yong Hou; Wei-Peng Li; Ji-Shun Yang
Journal:  World J Gastroenterol       Date:  2022-04-21       Impact factor: 5.374

7.  Complementary and alternative medicine use in chronic liver disease patients.

Authors:  Leah M Ferrucci; Beth P Bell; Kathy B Dhotre; M Michele Manos; Norah A Terrault; Atif Zaman; Rosemary C Murphy; Grace R Vanness; Ann R Thomas; Stephanie R Bialek; Mayur M Desai; Andre N Sofair
Journal:  J Clin Gastroenterol       Date:  2010-02       Impact factor: 3.062

8.  Effect of Taijiquan assisted rehabilitation for breast cancer patients: A protocol for systematic review and meta-analysis.

Authors:  Sihua Zhao; Rongna Lian; Ruinian Zhang; Fanghong Wang; Hao Chen; Run Wan
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

Review 9.  Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities.

Authors:  Puiyan Lam; Fan Cheung; Hor Yue Tan; Ning Wang; Man Fung Yuen; Yibin Feng
Journal:  Int J Mol Sci       Date:  2016-03-29       Impact factor: 5.923

Review 10.  Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015.

Authors:  Hadi Darvishi Khezri; Ebrahim Salehifar; Mehrnoush Kosaryan; Aily Aliasgharian; Hossein Jalali; Arash Hadian Amree
Journal:  Adv Pharmacol Sci       Date:  2016-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.